Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jackie F Price
Affiliation
ORCID
Career Start Year
1996
Papers
175
H Index
60
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36670186
Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes.
Commun Med (Lond)
2023
36756713
Risk of dementia associated with body mass index, changes in body weight and waist circumference in older people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
2023
37172216
Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes.
2023
34932135
Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study.
Diabetologia
2022
35477395
Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.
Cardiovascular Diabetology
2022
35916147
Higher Arm Versus Lower Arm Systolic Blood Pressure and Cardiovascular Outcomes: a Meta-Analysis of Individual Participant Data From the INTERPRESS-IPD Collaboration.
Hypertension
2022
36691240
Association of functional health literacy and cognitive ability with self-reported diabetes in the English Longitudinal Study of Ageing: a prospective cohort study.
2022
34561430
Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease.
Nat Commun
2021
34160658
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes.
Diabetologia
2021
33517400
Genome-wide association study of circulating interleukin 6 levels identifies novel loci.
Hum Mol Genet
2021
33515071
Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
Diabetologia
2021
33558525
Publisher Correction: Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability.
Nat Commun
2021
33064180
Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation.
Diabetologia
2021
34631129
Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
Obesity Science and Practice
2021
32610336
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale.
Gerontology
2020
31996015
Triglyceride-containing lipoprotein sub-fractions and risk of coronary heart disease and stroke: A prospective analysis in 11,560 adults.
Eur J Prev Cardiol
2020
31619084
Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium.
Eur J Prev Cardiol
2020
32638496
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study.
Liver International
2020
31155658
The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies.
Am J Epidemiol
2019
30476079
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.
Eur Heart J
2019
30649175
Cardiovascular Risk Factors Associated With Venous Thromboembolism.
JAMA Cardiol
2019
29649236
Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration.
PLoS One
2018
30510157
GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes.
Nat Commun
2018
30017552
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
Lancet
2018
30235339
Correction: Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration.
PLoS One
2018
29676281
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599â¿¿912 current drinkers in 83 prospective studies.
Lancet
2018
29625295
Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally.
Atherosclerosis
2018
27908689
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.
Lancet Diabetes Endocrinol
2017
28500271
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.
Circulation
2017
28458444
Functional Analysis of the Coronary Heart Disease Risk Locus on Chromosome 21q22.
Disease Markers
2017
28456096
Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
Atherosclerosis
2017
28528401
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.
Diabetologia
2017
28525540
Alcohol Consumption and Common Carotid Intima-Media Thickness: The USE-IMT Study.
Alcohol and Alcoholism
2017
28323823
Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study.
PLoS ONE
2017
28777936
Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
Atherosclerosis
2017
27929198
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Thrombosis and Haemostasis
2017
27549350
Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids.
Cardiovascular Diabetology
2016
25416041
Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.
Eur J Prev Cardiol
2016
25869804
GWAS for executive function and processing speed suggests involvement of the CADM2 gene.
Mol Psychiatry
2016
26746227
Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?
Eur J Prev Cardiol
2016
27338949
Mendelian Randomisation study of the influence of eGFR on coronary heart disease.
Scientific Reports
2016
27280446
Replication and Characterization of Association between ABO SNPs and Red Blood Cell Traits by Meta-Analysis in Europeans.
PLoS One
2016
27365493
Marginal role for 53 common genetic variants in cardiovascular disease prediction.
Heart
2016
26781229
Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.
Lancet Diabetes Endocrinol
2016
27083286
Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
Kidney International
2016
27080315
Inter-arm blood pressure difference and mortality: a cohort study in an asymptomatic primary care population at elevated cardiovascular risk.
British Journal of General Practice
2016
26454513
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
QJM - Monthly Journal of the Association of Physicians
2016
25979724
Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.
Int J Epidemiol
2016
24474739
Mendelian randomization of blood lipids for coronary heart disease.
Eur Heart J
2015
25847351
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes.
Diabetologia
2015
1 - 50 of 175
Column Actions
Search
Recommended Authors
Collaborators
Mika Kivimäki
Co-authored papers
38
Aroon D Hingorani
Co-authored papers
35
Steve E Humphries
Co-authored papers
34
Meena Kumari
Co-authored papers
34
Albert Hofman
Harvard T.H. Chan School of Public Health
Co-authored papers
28
Nicholas J Wareham
Co-authored papers
26
Andrew Wong
Co-authored papers
23
Juan P Casas
Co-authored papers
23
Naveed Sattar
Co-authored papers
21
Claudia Langenberg
Co-authored papers
21
Debbie A Lawlor
Bristol Medical School, University of Bristol
Co-authored papers
21
Lars Lind
Co-authored papers
20
Jackie A Cooper
Co-authored papers
19
Yoav Ben-Shlomo
Co-authored papers
19
Anders Hamsten
Co-authored papers
18
Richard W Morris
School of Psychology and Sydney Medical School, The University of Sydney
Co-authored papers
17
James F Wilson
Co-authored papers
17
Andr?? G Uitterlinden
Erasmus University Medical Center
Co-authored papers
16
Philippa J Talmud
University of Bristol
Co-authored papers
16
Ulf de Faire
Co-authored papers
16
Maryam Kavousi
University Medical Center Rotterdam
Co-authored papers
15
Sonia Shah
Co-authored papers
15
Elena Tremoli
Co-authored papers
15
George Davey Smith
University of Bristol
Co-authored papers
14
Oscar H Franco
Institute of Social and Preventive Medicine (I.S.P.M.), University of Bern
Co-authored papers
14
Veikko Salomaa
Co-authored papers
13
Delilah Zabaneh
Co-authored papers
13
Harry Campbell
Co-authored papers
13
Luigi Ferrucci
National Institute on Aging, National Institutes of Health
Co-authored papers
13
Riccardo E Marioni
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers
13
1 - 30